Vinay Prasad Is Leaving the FDA / Anthropic Sues the Pentagon
WSJ Opinion: Potomac Watch
00:00
Standards for Rare Disease Trials
Discussion about appropriate trial designs for rare diseases and Prasad's insistence on large randomized trials.
Play episode from 05:56
Transcript
